A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 243(2022) vom: 11. Okt., Seite 109105
1. Verfasser: Wang, Xiaoxuan (VerfasserIn)
Weitere Verfasser: Hong, Yuheng, Meng, Shen, Gong, Wenchen, Ren, Tianyuan, Zhang, Tingting, Liu, Xianming, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Zhou, Shiyong, Zhao, Mengmeng, Zhai, Qiongli, Meng, Bin, Ren, Xiubao, Zhang, Huilai, Wang, Xianhuo
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't DLBCL Epigenetic signature Immune infiltration Prognosis Response Antibodies, Monoclonal, Murine-Derived Cytokines Myeloid Differentiation Factor 88 mehr... Cytarabine 04079A1RDZ Rituximab 4F4X42SYQ6 Vorinostat 58IFB293JI Vincristine 5J49Q6B70F Doxorubicin 80168379AG Cyclophosphamide 8N3DW7272P Histone Methyltransferases EC 2.1.1.- Protein Methyltransferases Prednisone VB0R961HZT